Moderna
MRNA
#1393
Rank
ยฃ10.40 B
Marketcap
ยฃ27.04
Share price
-3.92%
Change (1 day)
-65.92%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: ยฃ10.40 Billion

As of February 2025 Moderna has a market cap of ยฃ10.40 Billion. This makes Moderna the world's 1393th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ10.40 B-15.43%
2024ยฃ12.30 B-58.65%
2023ยฃ29.76 B-47.82%
2022ยฃ57.03 B-25.23%
2021ยฃ76.28 B151.54%
2020ยฃ30.32 B504.16%
2019ยฃ5.01 B26.92%
2018ยฃ3.95 B

End of Day market cap according to different sources

On Feb 6th, 2025 the market cap of Moderna was reported to be:

ยฃ10.40 Billion
by Yahoo Finance info icon info icon
ยฃ10.40 Billion
by CompaniesMarketCap info icon info icon
ยฃ10.40 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ยฃ66.93 M-99.36%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ179.21 B 1,622.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.67 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ28.87 B 177.48%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ172.24 B 1,555.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ2.06 B-80.20%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ297.37 B 2,757.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.39 B-76.98%๐Ÿ‡บ๐Ÿ‡ธ USA